Oral Oncol
-
Publication Venue For
- Prediction model to estimate overall survival benefit of postoperative radiotherapy for resected major salivary gland cancers.. 132:105955. 2022
- A novel surgeon credentialing and quality assurance process using transoral surgery for oropharyngeal cancer in ECOG-ACRIN Cancer Research Group Trial E3311.. 110:104797. 2020
- State Medicaid expansion status, insurance coverage and stage at diagnosis in head and neck cancer patients.. 110:104870. 2020
- Evaluating for disparities in place of death for head and neck cancer patients in the United States utilizing the CDC WONDER database.. 102:104555. 2020
- Prognostic significance of surgical margins after transoral laser microsurgery for early-stage glottic squamous cell carcinoma.. 97:105-111. 2019
- Impact of gender on the association between marital status and head and neck cancer outcomes.. 89:48-55. 2019
- Racial and socioeconomic disparities associated with 90-day mortality among patients with head and neck cancer in the United States.. 89:95-101. 2019
- The relative distribution of oral cancer in the United States by subsite.. 89:56-58. 2019
- Temporal lobe injury patterns following intensity modulated radiotherapy in a large cohort of nasopharyngeal carcinoma patients.. 85:8-14. 2018
- Induction chemotherapy with carboplatin, nab-paclitaxel and cetuximab for at least N2b nodal status or surgically unresectable squamous cell carcinoma of the head and neck.. 84:46-51. 2018
- An assessment of patient burdens from head and neck cancer survivorship care.. 82:115-121. 2018
- Factors associated with increased risk of suicide among survivors of head and neck cancer: A population-based analysis.. 81:29-34. 2018
- The risk of carotid stenosis in head and neck cancer patients after radiation therapy.. 80:9-15. 2018
- Pitfalls of post-treatment PET after de-intensified chemoradiotherapy for HPV-associated oropharynx cancer: Secondary analysis of a phase 2 trial.. 78:108-113. 2018
- 40-year incidence trends for oropharyngeal squamous cell carcinoma in the United States.. 74:90-97. 2017
- Survival after refusal of surgical treatment for locally advanced laryngeal cancer.. 71:34-40. 2017
- Competing causes of death in the head and neck cancer population.. 65:8-15. 2017
- Pathology-based staging for HPV-positive squamous carcinoma of the oropharynx.. 62:11-19. 2016
- Squamous cell carcinoma of the oral cavity often overexpresses p16 but is rarely driven by human papillomavirus.. 56:47-53. 2016
- Socioeconomic characteristics of patients with oropharyngeal carcinoma according to tumor HPV status, patient smoking status, and sexual behavior.. 51:832-838. 2015
- HPV16 antibodies as risk factors for oropharyngeal cancer and their association with tumor HPV and smoking status.. 51:662-667. 2015
- Racial disparities in squamous cell carcinoma of the oral tongue among women: a SEER data analysis.. 51:586-592. 2015
- Sexual behavior, HPV knowledge, and association with head and neck cancer among a high-risk group.. 51:452-456. 2015
- Assessment of the sensitivity and specificity of tissue-specific-based and anatomical-based optical biomarkers for rapid detection of human head and neck squamous cell carcinoma.. 50:848-856. 2014
- Phase II multicenter trial of Caphosol for the reduction of mucositis in patients receiving radiation therapy for head and neck cancer.. 50:765-769. 2014
- ACR Appropriateness Criteria® thyroid carcinoma.. 50:577-586. 2014
- Study of functional infrared imaging for early detection of mucositis in locally advanced head and neck cancer treated with chemoradiotherapy.. 49:1025-1031. 2013
- Performance and quality of life outcomes for T4 laryngeal cancer patients treated with induction chemotherapy followed by chemoradiotherapy.. 48:1025-1030. 2012
- Functional single-nucleotide polymorphisms in the BRCA1 gene and risk of salivary gland carcinoma.. 48:842-847. 2012
- ACR appropriateness criteria® adjuvant therapy for resected squamous cell carcinoma of the head and neck.. 47:554-559. 2011